期刊文献+

NP方案治疗晚期非小细胞肺癌近期疗效观察 被引量:4

Retrospective observation of NP treated advanced non-small-cell lung cancer
下载PDF
导出
摘要 目的 评价长春瑞滨加顺铂联合化疗方案对晚期非小细胞肺癌近期疗效。方法 对 6 4例晚期非小细胞肺癌患者应用NP方案化疗 ,观察近期疗效及毒副反应。结果 CR3例 ,PR32例 ,总有效率 5 4 7%。结论 NP方案治疗晚期非小细胞肺癌近期疗效较好 ,毒副反应小 ,为可逆性 ,值得临床推广。 Objective To evaluate the curative effect of NVB and Cis-dichlorodiamine platinum(NP) for non-small-cell lung cancer in late period.Methods It was observed that the curative and side-effect of NP for 64 cases of patients with non-small-cell lung cancer in late period. Results There were 3 case of CR and 32 casses of PR with54 7% total effective rate.Conclusion Non-small-cell lung cancer in late period is treated by NP with better theraputic effect and little side-effect.
出处 《现代肿瘤医学》 CAS 2003年第3期196-197,共2页 Journal of Modern Oncology
关键词 NP方案 治疗 晚期非小细胞肺癌 近期疗效 临床观察 毒副反应 长春瑞滨 顺铂 化疗 non-small-cell lung cancer NVB Cis-dichlorodiamine platinum
  • 相关文献

参考文献5

二级参考文献10

共引文献594

同被引文献25

  • 1潘启超.长春碱类的新进展──失碳长春碱[J].癌症,1996,15(3):228-231. 被引量:276
  • 2[2]Madajiewicz S,Chowhan N,Tfayli A,et al.Therapy for patients with high grad astrocytoma using intraarterial chemothererapy and radiation therpy[J].Cancer,2000,88 (10):2350 ~2356.
  • 3[3]Stefanini GF,Amorati P,Biselli M,et al.Efficacy of transarterial targeted treatments on survival of patiens with hepatocellular carcinoma[J].Cancer,1995,75 (10):2427 ~ 2434.
  • 4[4]Ishiawa H,Kikkawa F,Tamakoski K,et al.Distributtion of platinum in human gynecological tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy[J].Anticancer Res,1996,16 (6B):3849 ~ 3853.
  • 5[5]Gallo JM,Varkonyi P,Hassan EE,et al.Targeting anticancer Drugs to the brain:pharmacokinetic model of oxantrazole following intraarterial administration to rat glioma-2(RG-2) bearing rats[J].J pharmacokinet Biopharm,1993,21 (5):575 ~592.
  • 6[6]Kameyama M,Imaoka S,Fukuda I,et al.Delayed washout of intraetumor blood fiow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer[J].Surgery,1993,114(1):97 ~ 101.
  • 7Hotts K,Sekine I,TamuraT,et al. A phase Ⅰ/Ⅱ study of cisplatin and vinorelbine chemotherapy in patients with advanced nonsmall cell lung cancer[J]. Jpn J Clin Oncol2001,31 (12) :596 ~600.
  • 8Kell K,Crowley J,Bunn PA,et al. Randomized phase Ⅲ trial of comparing paclitaxel plus carboplatin(PC) versus vinorelbine plus ciaplatin(VC) in untreated advanced non- small cell lung cancer (NSCLC) :a Southwest Oncology Group (SWOG) trial[ C]. Proc Annu Meet Am Soc Clin Oncol,1999.18. Abstract 1777.
  • 9Tramura S, Negoro Y, Nishiwaki, et al. The four - arm cooperative study (FACS) for advanced non - small - cell lung cancer (NSCLC) [ C ]. Proc Annu Meet Am Soc Clin Oncol, 2004. 23.Abstract 7006.
  • 10Fossella FV,DeVore R,Kerr RN,et al. Randomized phase Ⅲ trial of docetaxel verse vinorelbine or ifofamide in patients with advanced non - small cell lung cancer previously treated with platinum - containing chemotherapy regimens: the TAX 320 non - small cell lung cancer study group[J]. J Clin Oncol,2000,18:2354 ~2362.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部